Paper Details

  1. Home
  2. Paper Details

Antibody response to 17D yellow fever vaccine in Ghanaian infants.

Author: AfariE A, DunyoS K, KoramK A, NkrumahF K, OdoomJ K, Osei-KwasiM

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

The 17D yellow fever vaccine could be recommended for use in children at 6 months in outbreak situations or in high risk endemic areas.
Paper Details　
Original Abstract of the Article :
OBJECTIVES: To assess the seroresponses to yellow fever vaccination at 6 and 9 months of age; assess any possible adverse effects of immunization with the 17D yellow fever vaccine in infants, particularly at 6 months of age. METHODS: Four hundred and twenty infants who had completed BCG, OPV and DP...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2566698/

データ提供：米国国立医学図書館（NLM）

Protecting Against Yellow Fever in Ghanaian Infants

The study focuses on the effectiveness of the 17D yellow fever vaccine in Ghanaian infants. Yellow fever is a dangerous disease transmitted by mosquitoes, and vaccination is crucial for protection. It's like building a protective barrier around a camel caravan, ensuring its safety against the dangers of the desert.

Effective Vaccine Protection for Ghanaian Infants

The researchers found that the 17D yellow fever vaccine effectively induces antibody responses in infants, providing protection against the disease. The study also suggests that vaccination at 6 months of age is safe and effective. It's like finding a reliable well in the desert, providing a vital source of protection and hydration.

Recommendations for High-Risk Areas

The findings suggest that the 17D yellow fever vaccine could be recommended for use in children at 6 months in outbreak situations or in high-risk endemic areas. This is crucial for safeguarding infants in areas where yellow fever poses a significant threat. It's like building a secure camp in the desert, offering a safe haven from potential dangers.

Dr.Camel's Conclusion

This research provides valuable information about the effectiveness and safety of the 17D yellow fever vaccine in Ghanaian infants. The findings are crucial for protecting vulnerable populations from this dangerous disease, ensuring a safer and healthier future. It's like equipping a camel caravan with the right tools to navigate the harsh desert environment, ensuring their survival and well-being.

Date :
  1. Date Completed 2002-01-07
  2. Date Revised 2009-05-29
Further Info :

Pubmed ID

11731813

DOI: Digital Object Identifier

PMC2566698

Related Literature

Article Analysis
・Effects of yellow fever vaccine
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.